1. 124P Phase II study of neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage IIIA-B N2 non-small cell lung cancer: SQUAT trial (WJOG 12119L). (December 2022) Authors: Miyoshi, T.; Hamada, A.; Soh, J.; Hata, A.; Nakamatsu, K.; Shimokawa, M.; Yatabe, Y.; Suzuki, J.; Tsuboi, M.; Horinouchi, H.; Yoshino, I.; Masayuki, T.; Toyooka, S.; Okada, M.; Go, T.; Yamashita, M.; Nishimura, Y.; Yamamoto, N.; Nakagawa, K.; Mitsudomi, T. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Frequency and features of myasthenia gravis developing after thymectomy. (12th August 2019) Authors: Uzawa, A.; Kanai, T.; Oda, F.; Ozawa, Y.; Yasuda, M.; Kawaguchi, N.; Himuro, K.; Yoshino, I.; Kuwabara, S. Journal: European journal of neurology Issue: Volume 27:Number 1(2020) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗